Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | ACE CL E G H | 1636 | 2707 | OMIM:267430 | Renal tubular dysgenesis | | | | 113 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | AGT CL E G H | 183 | 333 | OMIM:267430 | Renal tubular dysgenesis | | | | 48 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | AGTR1 CL E G H | 185 | 336 | OMIM:267430 | Renal tubular dysgenesis | | | | 33 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | APRT CL E G H | 353 | 626 | ORPHA:976 | Adenine phosphoribosyltransferase deficiency | | | | 19 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | APRT CL E G H | 353 | 626 | OMIM:614723 | Adenine phosphoribosyltransferase deficiency | | | | 19 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | C3 CL E G H | 718 | 1318 | OMIM:612925 | Hemolytic uremic syndrome, atypical, susceptibility to, 5 | | | | 92 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | CAV1 CL E G H | 857 | 1527 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 11 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | CCN2 CL E G H | 1490 | 2500 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | CCR6 CL E G H | 1235 | 1607 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | CD46 CL E G H | 4179 | 6953 | OMIM:612922 | Hemolytic uremic syndrome, atypical, susceptibility to, 2 | | | | 39 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | CFB CL E G H | 629 | 1037 | OMIM:612924 | Hemolytic uremic syndrome, atypical, susceptibility to, 4 | | | | 30 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | CFH CL E G H | 3075 | 4883 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | 86 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | CFHR1 CL E G H | 3078 | 4888 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | CFHR3 CL E G H | 10878 | 16980 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | | | | | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | CFI CL E G H | 3426 | 5394 | OMIM:612923 | Hemolytic uremic syndrome, atypical, susceptibility to, 3 | | | | 57 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | COX1 CL E G H | 4512 | 7419 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | COX3 CL E G H | 4514 | 7422 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | DZIP1L CL E G H | 199221 | 26551 | ORPHA:731 | Autosomal recessive polycystic kidney disease | | | | 4 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 2 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | IRF5 CL E G H | 3663 | 6120 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | | | | 4 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | LPIN1 CL E G H | 23175 | 13345 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | 95 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | MYH11 CL E G H | 4629 | 7569 | OMIM:619351 | MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 2; MMIHS2 | | | | 418 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | PAX2 CL E G H | 5076 | 8616 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 39 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | PBX1 CL E G H | 5087 | 8632 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 3 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | PKHD1 CL E G H | 5314 | 9016 | ORPHA:731 | Autosomal recessive polycystic kidney disease | | | | 563 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | REN CL E G H | 5972 | 9958 | OMIM:267430 | Renal tubular dysgenesis | | | | 25 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | RYR1 CL E G H | 6261 | 10483 | ORPHA:466650 | Exercise-induced malignant hyperthermia | | | | 1200 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | SLC22A12 CL E G H | 116085 | 17989 | OMIM:220150 | Hypouricemia, renal, 1 | | | | 56 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | SLC25A20 CL E G H | 788 | 1421 | ORPHA:159 | Carnitine-acylcarnitine translocase deficiency | | | | 40 | | |
HP:0011037 | HP:0011037 | Decreased urine output | 0 | THBD CL E G H | 7056 | 11784 | OMIM:612926 | Hemolytic uremic syndrome, atypical, susceptibility to, 6 | | | | 60 | | |
HP:0011037 | HP:0100519 | Anuria | 1 | ACE CL E G H | 1636 | 2707 | OMIM:267430 | Renal tubular dysgenesis | . | | | 113 | | |
HP:0011037 | HP:0100519 | Anuria | 1 | AGT CL E G H | 183 | 333 | OMIM:267430 | Renal tubular dysgenesis | . | | | 48 | | |
HP:0011037 | HP:0100519 | Anuria | 1 | AGTR1 CL E G H | 185 | 336 | OMIM:267430 | Renal tubular dysgenesis | . | | | 33 | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | APRT CL E G H | 353 | 626 | OMIM:614723 | Adenine phosphoribosyltransferase deficiency | | | | 19 | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | APRT CL E G H | 353 | 626 | ORPHA:976 | Adenine phosphoribosyltransferase deficiency | HP:0040283 - Occasional | | | 19 | | |
HP:0011037 | HP:0100519 | Anuria | 1 | C3 CL E G H | 718 | 1318 | OMIM:612925 | Hemolytic uremic syndrome, atypical, susceptibility to, 5 | . | | | 92 | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | CAV1 CL E G H | 857 | 1527 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | HP:0040281 - Very frequent | | | 11 | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | CCN2 CL E G H | 1490 | 2500 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | HP:0040281 - Very frequent | | | | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | CCR6 CL E G H | 1235 | 1607 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | HP:0040281 - Very frequent | | | | | |
HP:0011037 | HP:0100519 | Anuria | 1 | CD46 CL E G H | 4179 | 6953 | OMIM:612922 | Hemolytic uremic syndrome, atypical, susceptibility to, 2 | . | | | 39 | | |
HP:0011037 | HP:0100519 | Anuria | 1 | CFB CL E G H | 629 | 1037 | OMIM:612924 | Hemolytic uremic syndrome, atypical, susceptibility to, 4 | . | | | 30 | | |
HP:0011037 | HP:0100519 | Anuria | 1 | CFH CL E G H | 3075 | 4883 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | 86 | | |
HP:0011037 | HP:0100519 | Anuria | 1 | CFHR1 CL E G H | 3078 | 4888 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | | | |
HP:0011037 | HP:0100519 | Anuria | 1 | CFHR3 CL E G H | 10878 | 16980 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | | | |
HP:0011037 | HP:0100519 | Anuria | 1 | CFI CL E G H | 3426 | 5394 | OMIM:612923 | Hemolytic uremic syndrome, atypical, susceptibility to, 3 | . | | | 57 | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | COX1 CL E G H | 4512 | 7419 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | COX3 CL E G H | 4514 | 7422 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | DZIP1L CL E G H | 199221 | 26551 | ORPHA:731 | Autosomal recessive polycystic kidney disease | HP:0040283 - Occasional | | | 4 | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | HP:0040281 - Very frequent | | | 2 | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | IRF5 CL E G H | 3663 | 6120 | ORPHA:220393 | Diffuse cutaneous systemic sclerosis | HP:0040281 - Very frequent | | | 4 | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | LPIN1 CL E G H | 23175 | 13345 | ORPHA:99845 | Genetic recurrent myoglobinuria | | | | 95 | | |
HP:0011037 | HP:0100519 | Anuria | 1 | MYH11 CL E G H | 4629 | 7569 | OMIM:619351 | MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME 2; MMIHS2 | | | | 418 | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | PAX2 CL E G H | 5076 | 8616 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 39 | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | PBX1 CL E G H | 5087 | 8632 | ORPHA:97362 | Renal hypoplasia, bilateral | | | | 3 | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | PKHD1 CL E G H | 5314 | 9016 | ORPHA:731 | Autosomal recessive polycystic kidney disease | HP:0040283 - Occasional | | | 563 | | |
HP:0011037 | HP:0100519 | Anuria | 1 | REN CL E G H | 5972 | 9958 | OMIM:267430 | Renal tubular dysgenesis | . | | | 25 | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | RYR1 CL E G H | 6261 | 10483 | ORPHA:466650 | Exercise-induced malignant hyperthermia | HP:0040283 - Occasional | | | 1200 | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | SLC22A12 CL E G H | 116085 | 17989 | OMIM:220150 | Hypouricemia, renal, 1 | | | | 56 | | |
HP:0011037 | HP:0100520 | Oliguria | 1 | SLC25A20 CL E G H | 788 | 1421 | ORPHA:159 | Carnitine-acylcarnitine translocase deficiency | HP:0040283 - Occasional | | | 40 | | |
HP:0011037 | HP:0100519 | Anuria | 1 | THBD CL E G H | 7056 | 11784 | OMIM:612926 | Hemolytic uremic syndrome, atypical, susceptibility to, 6 | . | | | 60 | | |